Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Audio Recap

Source: IDWeek 2021: Clinical Impact of New Data*
September 29 - October 3, 2021; Virtual
Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Released: December 6, 2021

In this episode, Martin C. Mahoney, MD, PhD, discusses new data on vaccine-preventable diseases from IDWeek 2021, including:

  • Pneumococcal disease
  • Respiratory syncytial virus (RSV)
  • Herpes zoster
  • Influenza

Information on this Educational Activity

Faculty

Martin C. Mahoney, MD, PhD

Professor of Oncology
Department of Internal Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Martin C. Mahoney, MD, PhD, has disclosed that he has received consulting fees from Merck, Pfizer, and Sanofi; fees for non-CME/CE services from GlaxoSmithKline, Merck, Pfizer, and Sanofi; and other financial or material support from Pfizer.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Dr Kristen Marks on COVID-19 second booster dose: indication, which vaccine, and timing, from Clinical Care Options (CCO)

Kristen Marks, MD Released: May 20, 2022

Expert commentary on new data in RSV epidemiology from ECCMID 2022, as reported by Clinical Care Options (CCO)

Ting Shi, PhD Released: May 19, 2022

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 18, 2022

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 17, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings